Trial · NCT00661141
Results by group240
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 240
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 1.0 mg/kg | Any AE | 13 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 3.0 mg/kg | Any AE | 6 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 5.0 mg/kg | Any AE | 8 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Pooled Placebo | Any AE | 21 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Overall | Any AE | 28 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 1.0 mg/kg | Mild AE | 13 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 3.0 mg/kg | Mild AE | 6 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 5.0 mg/kg | Mild AE | 8 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Pooled Placebo | Mild AE | 19 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Overall | Mild AE | 28 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 1.0 mg/kg | Moderate AE | 2 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 3.0 mg/kg | Moderate AE | 0 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 5.0 mg/kg | Moderate AE | 0 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Pooled Placebo | Moderate AE | 5 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Overall | Moderate AE | 7 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 1.0 mg/kg | Severe AE | 0 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 3.0 mg/kg | Severe AE | 0 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Antizol 5.0 mg/kg | Severe AE | 0 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Pooled Placebo | Severe AE | 0 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation | Overall | Severe AE | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00661141/results